|Items||Size （2mg）||Size（5mg X 2）|
|Particle size||2 μm||2 μm|
|Coupled amount of protein||>172 pmol (15 μg) ACE2 / mg Beads||>172 pmol (15 μg) ACE2 / mg Beads|
|Capacity||>20 μg Spike S1 / mg beads; >20 μg Spike RBD / mg beads||>20 μg Spike S1 / mg beads; >20 μg Spike RBD / mg beads|
|Formulation||PBS, pH7.4, with 10% Trehalose||PBS, pH7.4, with 10% Trehalose|
|Reconstitution||2 mL ultrapure water (1 mg beads / mL)||Reconstitute 5 mg / bottle Beads with 5 mL ultrapure water (1 mg beads / mL)|
|Concentration||1 mg beads / mL||1 mg beads / mL|
Upon receipt, please store the Beads at -20℃. The shelf life is 1 year at -20 ℃.
Please avoid more than 3 freeze-thaw cycles. Immediate use after reconstitution is highly recommended.
a) Reconstitute the Beads following the COA. Wash and re-suspended the beads to a certain concentration by adding your dilution buffer.
b) Add the prepared beads to your samples.
c) Beads can be separated from your samples afterwards using a magnetic plate.
Immobilized 15 μg ACE2 protein to 1 mg Beads, can bind the SARS-CoV-2 S1 protein, Fc Tag (Cat. No. S1N-C5255) with an EC50 of 1.402 μg/mL (QC tested).
Immobilized 15 μg ACE2 protein to 1 mg Beads, can bind the SARS-CoV-2 S protein RBD, Fc Tag (Cat. No. SPD-C5255) with an EC50 of 0.5095 μg/mL (QC tested).
ACROBiosystems has developed a series of critical reagents for COVID-19 vaccine development and evaluation,including proteins, antibodies and kits. These featured products are suitable for IgG/M antibody titer detection, neutralizing antibody titer detection and antigen titer detection.
High quality SARS-CoV-2 S protein, S1 protein and human ACE2 protein based on the human cell expression platform of HEK293.
ACROBiosystems has developed a serial of high-quality antigen and antibody reagents, including super stable trimeric S protein, S RBD, S1, S2, N proteins mainly expressed by HEK 293 and paired antibodies with outstanding sensitivity verified by inactivated virus samples.
ACROBiosystems has developed a series of kit products using its high-quality SARS-CoV-2 antigen proteins to improve the efficiency of anti-SARS-CoV-2 drugs and vaccines development.
This web search service is supported by Google Inc.